Factors Contributing to the Preference of Korean Patients with Crohn's Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)

Gut and Liver
Eun Soo KimIBD Study Group of the Korean Association for the Study of the Intestinal Diseases (KASID)

Abstract

Two comparable anti-tumor necrosis factor (TNF) agents with different routes of administration (intravenous [iv] infliximab [IFX] vs subcutaneous [sc] adalimumab [ADA]) are available for patients with Crohn's disease (CD) in Korea. This study aimed to identify the preferences of Korean CD patients for a specific anti-TNF agent and the factors contributing to the decision. A prospective survey was performed among anti-TNF-naive CD patients in 10 tertiary referral hospitals. A 16-item questionnaire addressed patient preferences and the factors contributing to the decision in favor of a particular anti-TNF agent. A logistic regression was conducted to assess predictive factors for ADA preference. Overall, 189 patients (139 males; mean age, 32.47±11.71 years) completed the questionnaire. IFX and ADA were preferred by 63.5% (120/189) and 36.5% (69/189) of patients, respectively. The most influential reason for choosing IFX was 'doctor's presence' (68.3%, 82/120), and ADA was "easy to use" (34.8%, 24/69). Amid various clinicodemographic data, having a >60-minute travel time to the hospital was a significant independent predictive factor for ADA preference. A large number of anti-TNF-naive Korean patients with CD preferred anti-TNFs w...Continue Reading

References

Jul 1, 1997·Medical Decision Making : an International Journal of the Society for Medical Decision Making·R L Street, B Voigt
Jul 29, 1998·Social Science & Medicine·E Guadagnoli, P Ward
May 31, 2001·Psychological Review·R E NisbettA Norenzayan
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Nov 7, 2006·Rheumatology·E L Williams, C J Edwards
Aug 30, 2007·Musculoskeletal Care·Frances Chilton, Raymond A Collett
Nov 27, 2007·Nature Clinical Practice. Rheumatology·Bart J F van den Bemt, Wim G J M van Lankveld
Jan 24, 2009·Medical Care·Florina ConstantinescuLiana Fraenkel
Apr 1, 2009·Arthritis and Rheumatism·Florina ConstantinescuLiana Fraenkel
Mar 10, 2010·Current Drug Targets·Gert van AsschePaul Rutgeerts
Oct 12, 2011·Inflammatory Bowel Diseases·Stephan R VavrickaUNKNOWN Swiss IBDnet and Swiss IBD Cohort Study Group
Mar 6, 2012·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Chang Hwan ChoiUNKNOWN IBD Study Group of the Korean Association for the Study of Intestinal Diseases
Mar 6, 2012·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Byong Duk YeUNKNOWN IBD Study Group of the Korean Association for the Study of the Intestinal Diseases
Apr 30, 2013·Current Drug Targets·Michael ScharlGerhard Rogler
Jul 9, 2013·Journal of Gastroenterology and Hepatology·Kang-Moon LeeUNKNOWN IBD study Group of Korean Association for the Study of Intestinal Diseases
Feb 1, 2014·Alimentary Pharmacology & Therapeutics·T LobatónP Rutgeerts
Sep 18, 2014·The Korean Journal of Internal Medicine·Kang-Moon Lee, Ji Min Lee

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.